| Dr Daniel Michael Navin, MD | |
|
5087 N Royal Dr, Traverse City, MI 49684-6987 | |
| (231) 935-0440 | |
| (231) 935-0445 |
| Full Name | Dr Daniel Michael Navin |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 34 Years |
| Location | 5087 N Royal Dr, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366448995 | NPI | - | NPPES |
| 290009655 | Other | MI | RAILROAD MEDICARE |
| 290B81008 | Other | MI | BCBS |
| 3347820 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301069701 (Michigan) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 4301069701 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Munson Healthcare Cadillac Hospital | Cadillac, MI | Hospital |
| Paul Oliver Memorial Hospital | Frankfort, MI | Hospital |
| Munson Healthcare Manistee Hospital | Manistee, MI | Hospital |
| Kalkaska Memorial Health Center | Kalkaska, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Medical Center | 3072426287 | 257 |
News Archive
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
Researchers have, for the first time, isolated exercise as the key factor in triggering the production of functional new cells in the learning and memory centre of the brain.
For the many men diagnosed with testosterone deficiency, losing weight can help increase testosterone levels.
Genetics researchers at the University of Adelaide have solved a 40-year mystery for a family beset by a rare intellectual disability - and they've discovered something new about the causes of intellectual disability in the process.
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
Researchers have, for the first time, isolated exercise as the key factor in triggering the production of functional new cells in the learning and memory centre of the brain.
For the many men diagnosed with testosterone deficiency, losing weight can help increase testosterone levels.
Genetics researchers at the University of Adelaide have solved a 40-year mystery for a family beset by a rare intellectual disability - and they've discovered something new about the causes of intellectual disability in the process.
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336175165 PECOS PAC ID: 3072426287 Enrollment ID: O20051109000463 |
News Archive
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
Researchers have, for the first time, isolated exercise as the key factor in triggering the production of functional new cells in the learning and memory centre of the brain.
For the many men diagnosed with testosterone deficiency, losing weight can help increase testosterone levels.
Genetics researchers at the University of Adelaide have solved a 40-year mystery for a family beset by a rare intellectual disability - and they've discovered something new about the causes of intellectual disability in the process.
› Verified 1 days ago
| Entity Name | Pulmonary And Critical Care Of Northwest Michigan, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679575971 PECOS PAC ID: 4284734708 Enrollment ID: O20070713000134 |
News Archive
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
Researchers have, for the first time, isolated exercise as the key factor in triggering the production of functional new cells in the learning and memory centre of the brain.
For the many men diagnosed with testosterone deficiency, losing weight can help increase testosterone levels.
Genetics researchers at the University of Adelaide have solved a 40-year mystery for a family beset by a rare intellectual disability - and they've discovered something new about the causes of intellectual disability in the process.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Michael Navin, MD 5087 N Royal Dr Ste B, Traverse City, MI 49684-6987 Ph: (231) 935-0440 | Dr Daniel Michael Navin, MD 5087 N Royal Dr, Traverse City, MI 49684-6987 Ph: (231) 935-0440 |
News Archive
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
Researchers have, for the first time, isolated exercise as the key factor in triggering the production of functional new cells in the learning and memory centre of the brain.
For the many men diagnosed with testosterone deficiency, losing weight can help increase testosterone levels.
Genetics researchers at the University of Adelaide have solved a 40-year mystery for a family beset by a rare intellectual disability - and they've discovered something new about the causes of intellectual disability in the process.
› Verified 1 days ago
John P Milliken, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 224 Circle Dr, Traverse City, MI 49684 Phone: 231-935-0525 Fax: 231-935-0529 | |
Dr. David R Hendricks, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 E Front St, Traverse City, MI 49684 Phone: 231-941-6670 Fax: 231-941-6675 | |
Dr. Jill Elizabeth Vollbrecht, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5015 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0850 Fax: 231-935-0850 | |
Dr. Katrina Marie Lawrence-wolff, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste A, Traverse City, MI 49684 Phone: 231-935-8330 Fax: 231-935-3437 | |
Steven M. Lamie, M. D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3537 W Front St, Suite I, Traverse City, MI 49684 Phone: 231-935-8950 Fax: 231-935-8868 | |
Anne M Hepner, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Suite 200, Traverse City, MI 49684 Phone: 231-935-5800 Fax: 231-935-5799 | |
Mark V Galan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 208, Traverse City, MI 49684 Phone: 231-935-5710 Fax: 231-935-9045 |